FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091971700> ?p ?o ?g. }

• W2091971700 endingPage "1519" @default.
• W2091971700 startingPage "1515" @default.
• W2091971700 abstract "Purpose To determine the long-term outcomes and prognostic factors in benign intracranial meningiomas treated with gamma knife stereotactic radiosurgery (GK-SRS). Methods and materials Between 1992 and 2000, 162 patients with benign meningiomas were treated with GK-SRS at the University of Maryland Medical Center. Complete follow-up was available in 137 patients. All patients underwent magnetic resonance imaging (MRI)-based treatment planning. Serial MRIs and clinical exams were performed to assess tumor response. GK-SRS was the primary treatment in 85 patients (62%), whereas 52 patients (48%) had prior surgical resections. The median prescribed dose was 14 Gy (range, 4–25 Gy) to the 50% isodose line. The median tumor volume, treatment volume, and conformity index were 4.5 cc (range, 0.32–80.0 cc), 6.3 cc (range, 1.0–75.2 cc), and 1.34 (range, 0.65–3.16), respectively. The median follow-up for the entire cohort was 4.5 years (range, 0.33–10.5 years). The following factors were included in the statistical analysis for disease-free survival (DFS) and overall survival (OS): sex, age, dose, gross tumor volume (GTV), conformity index (CI), and dural tail coverage. Results Serial MRI analysis was available in 121 patients (88.3%). Decrease in tumor size was observed in 34 patients (28.1%), whereas there was no change in 77 patients (63.6%), for a crude radiographic control rate of 91.7%. Increase in tumor size was seen in 10 patients (8.3%). New neurologic deficits attributed to the treatment developed in 10 patients (8.3%). The mean DFS and OS for the entire cohort are 4.6 years and 5.0 years, respectively. The 5-year actuarial DFS and OS were 86.2% and 91.0%, respectively. Univariate analysis revealed GTV, sex, CI, and dural tail treatment to be significant prognostic factors. Patients with GTV ≤10 cc also had longer survivals, with the 5-years DFS and OS of 91.9% vs. 68.0% (p = 0.038) and 100% vs. 59.7% (p = 0.0001), respectively. The 5-years actuarial DFS and OS for females vs. males were 90.2% vs. 74.2% (p = 0.0094) and 91.6% vs. 89.1% (p = 0.016), respectively. Patients with CI ≥1.4 achieved a longer DFS, with a 5-year DFS of 95.2% vs. 77.3% (p = 0.01). Patients who had the dural tail treated also had higher 5-year DFS (96.0% vs. 77.9%, p = 0.038). Patients with lower conformity (i.e., CI ≥1.4) tended to have the dural tail covered in the prescription isodose line (p = 0.04). The only factor significant in the multivariate analysis was for patients with GTV >10 cc, who had a worse DFS (hazard ratio 4.58, p = 0.05). Conclusions This report adds to the literature that supports the efficacy and safety of GK-SRS in the management of patients with benign intracranial meningiomas. Our report identified male patients, patients with a CI <1.4, and tumor size greater than 10 cc to have a worse prognosis. Patients who were treated with less conformal plans to cover the dural tail had better outcomes. Our data clearly demonstrate the need to adequately cover the dural tail in patients treated with GK-SRS for benign intracranial meningiomas. To determine the long-term outcomes and prognostic factors in benign intracranial meningiomas treated with gamma knife stereotactic radiosurgery (GK-SRS). Between 1992 and 2000, 162 patients with benign meningiomas were treated with GK-SRS at the University of Maryland Medical Center. Complete follow-up was available in 137 patients. All patients underwent magnetic resonance imaging (MRI)-based treatment planning. Serial MRIs and clinical exams were performed to assess tumor response. GK-SRS was the primary treatment in 85 patients (62%), whereas 52 patients (48%) had prior surgical resections. The median prescribed dose was 14 Gy (range, 4–25 Gy) to the 50% isodose line. The median tumor volume, treatment volume, and conformity index were 4.5 cc (range, 0.32–80.0 cc), 6.3 cc (range, 1.0–75.2 cc), and 1.34 (range, 0.65–3.16), respectively. The median follow-up for the entire cohort was 4.5 years (range, 0.33–10.5 years). The following factors were included in the statistical analysis for disease-free survival (DFS) and overall survival (OS): sex, age, dose, gross tumor volume (GTV), conformity index (CI), and dural tail coverage. Serial MRI analysis was available in 121 patients (88.3%). Decrease in tumor size was observed in 34 patients (28.1%), whereas there was no change in 77 patients (63.6%), for a crude radiographic control rate of 91.7%. Increase in tumor size was seen in 10 patients (8.3%). New neurologic deficits attributed to the treatment developed in 10 patients (8.3%). The mean DFS and OS for the entire cohort are 4.6 years and 5.0 years, respectively. The 5-year actuarial DFS and OS were 86.2% and 91.0%, respectively. Univariate analysis revealed GTV, sex, CI, and dural tail treatment to be significant prognostic factors. Patients with GTV ≤10 cc also had longer survivals, with the 5-years DFS and OS of 91.9% vs. 68.0% (p = 0.038) and 100% vs. 59.7% (p = 0.0001), respectively. The 5-years actuarial DFS and OS for females vs. males were 90.2% vs. 74.2% (p = 0.0094) and 91.6% vs. 89.1% (p = 0.016), respectively. Patients with CI ≥1.4 achieved a longer DFS, with a 5-year DFS of 95.2% vs. 77.3% (p = 0.01). Patients who had the dural tail treated also had higher 5-year DFS (96.0% vs. 77.9%, p = 0.038). Patients with lower conformity (i.e., CI ≥1.4) tended to have the dural tail covered in the prescription isodose line (p = 0.04). The only factor significant in the multivariate analysis was for patients with GTV >10 cc, who had a worse DFS (hazard ratio 4.58, p = 0.05). This report adds to the literature that supports the efficacy and safety of GK-SRS in the management of patients with benign intracranial meningiomas. Our report identified male patients, patients with a CI <1.4, and tumor size greater than 10 cc to have a worse prognosis. Patients who were treated with less conformal plans to cover the dural tail had better outcomes. Our data clearly demonstrate the need to adequately cover the dural tail in patients treated with GK-SRS for benign intracranial meningiomas." @default.
• W2091971700 created "2016-06-24" @default.
• W2091971700 creator A5004217393 @default.
• W2091971700 creator A5016634929 @default.
• W2091971700 creator A5052390076 @default.
• W2091971700 creator A5052573263 @default.
• W2091971700 creator A5061861625 @default.
• W2091971700 creator A5070621756 @default.
• W2091971700 creator A5074585611 @default.
• W2091971700 creator A5075326500 @default.
• W2091971700 creator A5076756822 @default.
• W2091971700 creator A5077051537 @default.
• W2091971700 date "2004-12-01" @default.
• W2091971700 modified "2023-10-01" @default.
• W2091971700 title "Factors predicting local tumor control after gamma knife stereotactic radiosurgery for benign intracranial meningiomas" @default.
• W2091971700 cites W1922259454 @default.
• W2091971700 cites W1968386365 @default.
• W2091971700 cites W1977075779 @default.
• W2091971700 cites W1981879141 @default.
• W2091971700 cites W1982116938 @default.
• W2091971700 cites W1983716488 @default.
• W2091971700 cites W2001068485 @default.
• W2091971700 cites W2004112197 @default.
• W2091971700 cites W2057428339 @default.
• W2091971700 cites W2060724712 @default.
• W2091971700 cites W2072506464 @default.
• W2091971700 cites W2075468175 @default.
• W2091971700 cites W2119023271 @default.
• W2091971700 cites W2138346035 @default.
• W2091971700 cites W2141324320 @default.
• W2091971700 cites W2158835756 @default.
• W2091971700 cites W2325150586 @default.
• W2091971700 cites W4323238477 @default.
• W2091971700 doi "https://doi.org/10.1016/j.ijrobp.2004.05.073" @default.
• W2091971700 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15590183" @default.
• W2091971700 hasPublicationYear "2004" @default.
• W2091971700 type Work @default.
• W2091971700 sameAs 2091971700 @default.
• W2091971700 citedByCount "206" @default.
• W2091971700 countsByYear W20919717002012 @default.
• W2091971700 countsByYear W20919717002013 @default.
• W2091971700 countsByYear W20919717002014 @default.
• W2091971700 countsByYear W20919717002015 @default.
• W2091971700 countsByYear W20919717002016 @default.
• W2091971700 countsByYear W20919717002017 @default.
• W2091971700 countsByYear W20919717002018 @default.
• W2091971700 countsByYear W20919717002019 @default.
• W2091971700 countsByYear W20919717002020 @default.
• W2091971700 countsByYear W20919717002021 @default.
• W2091971700 countsByYear W20919717002022 @default.
• W2091971700 countsByYear W20919717002023 @default.
• W2091971700 crossrefType "journal-article" @default.
• W2091971700 hasAuthorship W2091971700A5004217393 @default.
• W2091971700 hasAuthorship W2091971700A5016634929 @default.
• W2091971700 hasAuthorship W2091971700A5052390076 @default.
• W2091971700 hasAuthorship W2091971700A5052573263 @default.
• W2091971700 hasAuthorship W2091971700A5061861625 @default.
• W2091971700 hasAuthorship W2091971700A5070621756 @default.
• W2091971700 hasAuthorship W2091971700A5074585611 @default.
• W2091971700 hasAuthorship W2091971700A5075326500 @default.
• W2091971700 hasAuthorship W2091971700A5076756822 @default.
• W2091971700 hasAuthorship W2091971700A5077051537 @default.
• W2091971700 hasConcept C126322002 @default.
• W2091971700 hasConcept C126838900 @default.
• W2091971700 hasConcept C141071460 @default.
• W2091971700 hasConcept C143409427 @default.
• W2091971700 hasConcept C2779160599 @default.
• W2091971700 hasConcept C2780387249 @default.
• W2091971700 hasConcept C2780739268 @default.
• W2091971700 hasConcept C2989005 @default.
• W2091971700 hasConcept C3019894029 @default.
• W2091971700 hasConcept C509974204 @default.
• W2091971700 hasConcept C71924100 @default.
• W2091971700 hasConcept C72563966 @default.
• W2091971700 hasConceptScore W2091971700C126322002 @default.
• W2091971700 hasConceptScore W2091971700C126838900 @default.
• W2091971700 hasConceptScore W2091971700C141071460 @default.
• W2091971700 hasConceptScore W2091971700C143409427 @default.
• W2091971700 hasConceptScore W2091971700C2779160599 @default.
• W2091971700 hasConceptScore W2091971700C2780387249 @default.
• W2091971700 hasConceptScore W2091971700C2780739268 @default.
• W2091971700 hasConceptScore W2091971700C2989005 @default.
• W2091971700 hasConceptScore W2091971700C3019894029 @default.
• W2091971700 hasConceptScore W2091971700C509974204 @default.
• W2091971700 hasConceptScore W2091971700C71924100 @default.
• W2091971700 hasConceptScore W2091971700C72563966 @default.
• W2091971700 hasIssue "5" @default.
• W2091971700 hasLocation W20919717001 @default.
• W2091971700 hasLocation W20919717002 @default.
• W2091971700 hasOpenAccess W2091971700 @default.
• W2091971700 hasPrimaryLocation W20919717001 @default.
• W2091971700 hasRelatedWork W1500651153 @default.
• W2091971700 hasRelatedWork W1815512617 @default.
• W2091971700 hasRelatedWork W1971275301 @default.
• W2091971700 hasRelatedWork W2047967234 @default.
• W2091971700 hasRelatedWork W2077719154 @default.
• W2091971700 hasRelatedWork W2423336791 @default.
• W2091971700 hasRelatedWork W2439875401 @default.

• next